PMA device
Woven EndoBridge Aneurysm Embolization (WEB) System
MicroVention, Inc. · Intrasaccular Flow Disruption Device (OPR, Class III) · First FDA decision Dec 31, 2018, newest Mar 20, 2026Brain aneurysm
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
9
PMA pathway
Device trials
2
Naming "Woven EndoBridge Aneurysm"
MAUDE reports
0
Brand "Woven EndoBridge Aneurysm", since 2015
PubMed studies
6
Mentioning "Woven EndoBridge Aneurysm"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Woven EndoBridge Aneurysm Embolization (WEB) System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 9 decisions filed under this name.
- Woven EndoBridge Aneurysm Embolization (WEB) SystemPMA supplement
P170032-S019 · Decided Mar 20, 2026 · 260 days after receipt · Normal 180 Day Track No User Fee
Device type: Intrasaccular Flow Disruption Device (OPR) · Neurology & Neurosurgery
- Woven EndoBridge Aneurysm Embolization (WEB) SystemPMA supplement
P170032-S017 · Decided Sep 23, 2024 · 31 days after receipt · Normal 180 Day Track No User Fee
Device type: Intrasaccular Flow Disruption Device (OPR) · Neurology & Neurosurgery
- Woven EndoBridge (WEB) Aneurysm Embolization SystemPMA supplement
P170032-S016 · Decided Aug 14, 2024 · 83 days after receipt · Normal 180 Day Track No User Fee
Device type: Intrasaccular Flow Disruption Device (OPR) · Neurology & Neurosurgery
3 more FDA decisions with a free account
Older decisions: P170032-S002, P170032-S001, P170032
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Woven EndoBridge Aneurysm", any status and sponsor, newest update first.
Xuanwu Hospital, BeijingAcademic, hospital or other
NCT07620626 · 1,000 participants (planned) · Start Jun 10, 2026 · Primary completion Jun 30, 2028
Device: Intrasaccular Flow Disruption Device · For: Intracranial Aneurysm
Sites: Beijing, China
University Hospital, MontpellierAcademic, hospital or other
NCT04621552 · 186 participants · Start Jan 1, 2015 · Primary completion Jun 30, 2020
Device: WEB embolization · For: Aneurysm; Intracranial Aneurysm
Sites: Montpellier, France
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Woven EndoBridge Aneurysm", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OPR
933 reports: 484 malfunction, 413 injury, 36 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- WEB Detachment Controller, REF: WDC-2, WDC, MV-WDC2. Component of WEB Aneurysm Embolization System.Open, Classified
Z-0170-2023 · Started Sep 21, 2022 · Posted by FDA Nov 2, 2022
Reason given: Detachment controller, of an aneurysm embolization system, has an out of specification tunnel opening dimension, which may prevent the implant device pusher from being fully inserted into the controller, which may result in the inability of the controller to properly detach the implant device, which could cause delays...
Cause as FDA categorized it: Process control · Device type: Intrasaccular Flow Disruption Device (OPR)
Published research
The most relevant PubMed records for "Woven EndoBridge Aneurysm"[tiab]. The summary above synthesizes these.
- Decision-making tree for optimal Woven EndoBridge device sizing with ideal Woven EndoBridge-aneurysm volume (iWAVe) ratio.
Tanabe J, Nakahara I, Ishihara T, et al. · J Clin Neurosci · 2023
- Woven EndoBridge aneurysm treatment is associated with high feasibility, great safety, and very good efficacy also in long-term follow-up.
Pierot L, Spelle L · Interv Neuroradiol · 2026Letter
- The second-generation eCLIPs Endovascular Clip System: initial experience.
Chiu AH, De Vries J, O'Kelly CJ, et al. · J Neurosurg · 2018Multicenter Study
- Intraarterial encephalography from an acutely implanted aneurysm embolization device in awake humans.
Li L, Ibayashi K, Piscopo A, et al. · J Neurosurg · 2023
- Endovascular Treatment of a Direct Carotid Cavernous Sinus Fistula with the Woven EndoBridge Aneurysm Embolization System.
Tropine A, Moussa-Pacha A, Tritt S · Clin Neuroradiol · 2020Case Reports, Letter
- Are Anatomic Results Influenced by WEB Shape Modification? Analysis in a Prospective, Single-Center Series of 39 Patients with Aneurysms Treated with the WEB.
Herbreteau D, Bibi R, Narata AP, et al. · AJNR Am J Neuroradiol · 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.